ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Kane Biotech Inc

Kane Biotech Inc (KNE)

0.10
0.00
(0.00%)
Cerrado 17 Enero 3:00PM

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
0.10
Postura de Compra
0.10
Postura de Venta
0.105
Volume Operado de la Acción
2,500
0.10 Rango del Día 0.105
0.00 Rango de 52 semanas 0.00
Capitalización de Mercado [m]
Precio Anterior
0.10
Precio de Apertura
0.105
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
131,844,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-2.50
Beneficio por acción (BPA)
-0.04
turnover
2.82M
Beneficio neto
-5.27M

Acerca de Kane Biotech Inc

Sector
Coml Physical, Biologcl Resh
Industria
Coml Physical, Biologcl Resh
Sede
Winnipeg, Manitoba, Can
Fundado
-
Kane Biotech Inc is listed in the Coml Physical, Biologcl Resh sector of the TSX Venture Exchange with ticker KNE. The last closing price for Kane Biotech was $0.10. Over the last year, Kane Biotech shares have traded in a share price range of $ 0.00 to $ 0.00.

Kane Biotech currently has 131,844,000 shares in issue. The market capitalisation of Kane Biotech is $13.18 million. Kane Biotech has a price to earnings ratio (PE ratio) of -2.50.

KNE Últimas noticias

Kane Biotech Announces $3,000,000 Private Placement Offering

WINNIPEG, Manitoba, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces today that it intends to undertake a non-brokered...

Kane Biotech Announces Third Quarter 2024 Financial Results

WINNIPEG, Manitoba, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) today announces its third quarter 2024 financial...

Kane Biotech Announces Change in US Distribution Partner for revyve™ Antimicrobial Wound Gel

WINNIPEG, Manitoba, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane Biotech” or “Kane”) announces today that BioStem Technologies Inc...

Kane Biotech to Release Third Quarter 2024 Financial Results on November 28, 2024

WINNIPEG, Manitoba, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”) will release its third quarter 2024 financial results after market close on...

Kane Biotech Announces Health Canada Approval of revyve™ Antimicrobial Wound Gel

WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces today that it has received Health Canada approval of...

Kane Biotech Provides Investor Update Following FB Dermatology Acquisition Announcement

WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane Biotech”) announces today that President & CEO, Marc Edwards and Dr...

Kane Biotech Announces Agreement to Acquire FB Dermatology

WINNIPEG, Manitoba, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane Biotech”) announces today that it has entered into a binding term sheet...

Kane Biotech Announces Donation of revyve™ Antimicrobial Wound Gel to Ukraine

WINNIPEG, Manitoba, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it is donating 2,000 ounces of revyve™ Antimicrobial...

Kane Biotech Announces Exclusive Distribution Agreement With XSONX

WINNIPEG, Manitoba, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has signed an exclusive five year distribution...

Kane Biotech to Participate in a Multinational Corporate Collaboration Project

WINNIPEG, Manitoba, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) announces that it is receiving advisory services and...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

KNE - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Kane Biotech?
El precio actual de las acciones de Kane Biotech es $ 0.10
¿Cuántas acciones de Kane Biotech están en circulación?
Kane Biotech tiene 131,844,000 acciones en circulación
¿Cuál es la capitalización de mercado de Kane Biotech?
La capitalización de mercado de Kane Biotech es CAD 13.18M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Kane Biotech?
Kane Biotech ha negociado en un rango de $ 0.00 a $ 0.00 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Kane Biotech?
El ratio precio/beneficio de Kane Biotech es -2.5
¿Cuál es el ratio de efectivo a ventas de Kane Biotech?
El ratio de efectivo a ventas de Kane Biotech es 4.67
¿Cuál es la moneda de reporte de Kane Biotech?
Kane Biotech presenta sus resultados financieros en CAD
¿Cuál es el último ingresos anual de Kane Biotech?
El último ingresos anual de Kane Biotech es CAD 2.82M
¿Cuál es el último beneficio anual de Kane Biotech?
El último beneficio anual de Kane Biotech es CAD -5.27M
¿Cuál es la dirección registrada de Kane Biotech?
La dirección registrada de Kane Biotech es 290-100 INNOVATION DRIVE, WINNIPEG, MANITOBA, R3T 6G2
¿Cuál es la dirección del sitio web de Kane Biotech?
La dirección del sitio web de Kane Biotech es www.kanebiotech.com
¿En qué sector industrial opera Kane Biotech?
Kane Biotech opera en el sector COML PHYSICAL, BIOLOGCL RESH

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
AHRAmarc Resources Ltd
$ 0.72
(171.70%)
4.17M
OEG.HONEnergy Inc
$ 0.035
(133.33%)
14.66k
FYLFinlay Minerals Ltd
$ 0.045
(125.00%)
4.86M
CPICarlton Precious Inc
$ 0.16
(113.33%)
1,000
MVYMoovly Media Inc
$ 0.01
(100.00%)
1.5M
GAR.HGreen Arrow Resources Inc
$ 0.015
(-66.67%)
1.96k
CANDCandelaria Mining Corp
$ 0.005
(-50.00%)
553.7k
WWTWater Ways Technologies Inc
$ 0.005
(-50.00%)
79.65k
AZC.PA2ZCryptocap Inc
$ 0.045
(-50.00%)
33k
BYM.HBaymount Incorporated
$ 0.005
(-50.00%)
5k
FYLFinlay Minerals Ltd
$ 0.045
(125.00%)
4.86M
AGMRSilver Mountain Resources Inc
$ 0.05
(-9.09%)
4.23M
AHRAmarc Resources Ltd
$ 0.72
(171.70%)
4.17M
TDGTDG Gold Corp
$ 0.245
(75.00%)
4.08M
MATEBlockmate Ventures Inc
$ 0.33
(0.00%)
3.99M

KNE Discussion

Ver más
teq0904 teq0904 1 año hace
They have been making about 2,500 samples per month in their lab for distribution to doctors for more than a month. By the time the contract plant starts up at the end of March there will be over 10k samples out so lots of doctors will be familiar with the product. You can bet they went to the burn centers and other of their top identified markets first.
👍️0
teq0904 teq0904 1 año hace
Latest video on kne
https://www.facebook.com/KaneBiotechInc/videos/292568703569665
👍️0
teq0904 teq0904 1 año hace
cc on Tuesday
👍️0
teq0904 teq0904 1 año hace
Doesn't matter what you think the dog market is, because it will be sold. Strategic review nr.
👍️0
teq0904 teq0904 1 año hace
First closing of the financing is probably next week. Officers and directors are in on it.
👍️0
teq0904 teq0904 1 año hace
On the previous cc, Edwards said it is possible that the FDA will approve the manufacturing plant in time for the sales to start in Q4.
👍️0
teq0904 teq0904 1 año hace
The next quarterly cc will be late in August.
👍️0
teq0904 teq0904 1 año hace
The next step is for the outsourced manufacturing of coactiv+ to be completed. It may already be done, but it was supposed to take 3 months after receiving FDA approval.
👍️0
teq0904 teq0904 1 año hace
They have FDA approval for coactiv+.
👍️0
J_Dean J_Dean 4 años hace
This is the year. Let’s go! :)
👍️0
Golden Cross Golden Cross 5 años hace
Kane Biotech Announces Third Quarter 2019
Financial Results

https://backend.otcmarkets.com/otcapi/company/dns/news/document/40388/content
👍️0
Golden Cross Golden Cross 5 años hace
KNBIF Website:

https://www.kanebiotech.com/
👍️0
Golden Cross Golden Cross 5 años hace
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (56 patents and patents pending, trade secrets and trademarks) and products developed by the Company’s own biofilm research expertise and acquired from leading research institutions. StrixNBTM, DispersinB®, Aledex®, bluestemTM, AloSeraTM, coactiv+TM and Kane® are trademarks of Kane Biotech Inc. The Company is listed on the TSX Venture Exchange under the symbol "KNE".
👍️0
Golden Cross Golden Cross 5 años hace
Monster # of filings today $KNBIF

https://www.otcmarkets.com/stock/KNBIF/disclosure
👍️0
sfld sfld 5 años hace
This might pump this week. Mentioned in a National Inflation Association newsletter today. GLTA
👍️0
pegcitygreen pegcitygreen 6 años hace
I live in Winnipeg and have personally worked with this company. Great people, great products, but the company itself always seems to struggle. Kane products are for wealthy/well off people who love their pets and more than likely do not have any kids. A very, very niche market. Their tradeshows booth is quite impressive...but that doesn't mean impressive sales.
👍️0
teq0904 teq0904 6 años hace
CEO got 2M shares in the market now.
👍️0
teq0904 teq0904 6 años hace
Jan 30 cc and presentation shows the potential markets. Just sign into it and you end up with the archive. https://edge.media-server.com/m6/p/rzpqebyy
👍️0
Macaveli Macaveli 6 años hace
Decent news released today. Plus insiders are buying. This is a hidden gem.
👍️0
teq0904 teq0904 6 años hace
Sales are slow for this startup, however the products are superb so I imagine it will be a good company in the long run. I used the oral rinse and shampoo for my dog. I don't know if the rinse is the reason, but the vet told me this month that her teeth are in excellent shape for her age.
She also had a bad itch last winter and scratched day and night. It didn't stop with the use of a vet's prescription shampoo, so I tried the Kane product with excellent results. As soon as I put it on her she stops scratching for about 1 day, so I just apply it once daily wherever I see her scratching.

I know a guy who had terrible psoriasis itching on the scalp all day and night long but it all stopped when he used the human shampoo.
👍️0

Su Consulta Reciente

Delayed Upgrade Clock